Post-acute COVID-19 syndrome for anesthesiologists: a narrative review and a pragmatic approach to clinical care

R Kopanczyk, N Kumar, T Papadimos - Journal of Cardiothoracic and …, 2022 - Elsevier
Post-acute coronavirus disease 2019 (COVID-19) syndrome is a novel, poorly understood
clinical entity with life-impacting ramifications. Patients with this syndrome, also known as" …

[HTML][HTML] Thrombophilia genetic mutations and their relation to disease severity among patients with COVID-19

H Moness, SO Mousa, SO Mousa, NM Adel… - Plos one, 2024 - journals.plos.org
Objectives Patients with COVID-19 infection appear to develop virus-induced
hypercoagulability resulting in numerous thrombotic events. The aim of the present study …

[HTML][HTML] Herbal supplements as treatment options for COVID-19: A call for clinical development of herbal supplements for emerging and re-emerging viral threats in …

AA Onyeaghala, AF Anyiam, DC Husaini… - Scientific African, 2023 - Elsevier
The advent of Corona virus Disease 2019 (COVID-19) distorted health systems of many
countries. Efforts have been made to either develop new treatment solutions such as …

[HTML][HTML] COVID-19 infection as a new risk factor for penile Mondor disease

K Balawender, A Pliszka, A Surowiec, S Rajda - BMC urology, 2022 - Springer
Abstract Background Penile Mondor disease is a superficial dorsal vein thrombophlebitis of
the penis, which mainly affects young and middle-aged men. It generally manifests as a …

Multi-ancestry GWAS for venous thromboembolism identifies novel loci followed by experimental validation in zebrafish

BN Wolford, Y Zhao, I Surakka, KHH Wu, X Yu… - MedRxiv, 2022 - medrxiv.org
Genome wide association study (GWAS) results for Venous Thromboembolism (VTE) across
9 international cohorts of the Global Biobank Meta-analysis Initiative (GBMI), with …

[HTML][HTML] Clinical characteristics of COVID-19 associated vasculopathic diseases

T Greistorfer, P Jud - Thrombosis Journal, 2023 - Springer
Abstract Coronavirus disease 19 (COVID-19) has shown to be an infectious disease
affecting not only of the respiratory system, but also cardiovascular system leading to …

Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and …

SK Murthy, ME Kuenzig, JW Windsor… - Journal of the …, 2021 - academic.oup.com
The COVID-19 pandemic has ushered a globally focused vaccine development program
that produced multiple successful vaccines within a year. Four SARS-CoV-2 vaccines have …

[HTML][HTML] Integral assays of hemostasis in hospitalized patients with COVID-19 on admission and during heparin thromboprophylaxis

AY Bulanov, EL Bulanova, IB Simarova, EA Bovt… - PLoS …, 2023 - journals.plos.org
Background Blood coagulation abnormalities play a major role in COVID-19
pathophysiology. However, the specific details of hypercoagulation and anticoagulation …

COVID-19 and venous thromboembolism risk in patients with sickle cell disease

A Singh, AM Brandow, T Wun, AS Shet - Blood advances, 2022 - ashpublications.org
Venous thromboembolism (VTE) is a life-threatening complication observed among patients
with sickle cell disease (SCD) and also among those with severe COVID-19 infection …

[HTML][HTML] COVID-19 severity potentially modulated by cardiovascular-disease-associated immune dysregulation

AC Lee, G Castaneda, WT Li, C Chen, N Shende… - Viruses, 2021 - mdpi.com
Patients with underlying cardiovascular conditions are particularly vulnerable to severe
COVID-19. In this project, we aimed to characterize similarities in dysregulated immune …